TradingMenu expanded
Forge Markets Forge Pro Browse Companies
DataMenu expanded
Forge Data Private Market Index Forge Accuidity Index IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies In Europe
InsightsMenu expanded
All Insights Blog Glossary Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Updates Forge Investment Outlook Startup News Tech IPO Calendar for 2024
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Forge Pro
Browse Companies
Data Menu expandedData
Forge Data
Private Market Index
Forge Accuidity Index
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
In Europe
Insights Menu expandedInsights
All Insights
Blog
Glossary
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Updates
Forge Investment Outlook
Startup News
Tech IPO Calendar for 2024
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Private Companies / Generation Bio Stock

Generation Bio Stock

generationbio.comHealthcare / BioTech & PharmaFounded: 2016Funding to Date: $125.37MM

Generation Bio is an innovative genetic medicines company focused on creating a new class of gene therapy to provide durable, redosable treatments for patients suffering from both rare and prevalent diseases.

Buy or sell Generation Bio stockLearn more about Generation Bio IPO

Register To Buy and Sell Shares

For more details on financing and valuation for Generation Bio, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Generation Bio’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Generation Bio.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Thomas Graney
Chief Financial Officer
Will McCarthy
Chief Business Officer
Jason Rhodes
Chairman & Co-Founder
Mark Angelino Ph.D
Chief Operating Officer & Co-Founder
Robert Kotin Ph.D
Co-Founder & Head of Discovery
Geoffrey McDonough MD
Chief Executive Officer, President & Board Member
Jennifer Elliott Ph.D
Vice President, Head of Legal Affairs and Intellectual Property

Board Members

Donald Nicholson Ph.D
Anthony Quinn Ph.D
Geoffrey McDonough MD
Gustav Christensen
Jeffrey Jonas MD
Catherine Stehman-Breen MD
Jason Rhodes

Frequently Asked Questions About Generation Bio’s Stock

plusminus
Can you buy Generation Bio’s stock?
Generation Bio is not publicly traded on NYSE or NASDAQ in the U.S. To buy Generation Bio’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell Generation Bio’s stock?
Yes, you can sell stock of a private company like Generation Bio. Forge can help you sell your Generation Bio stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is Generation Bio’s stock price?
Generation Bio is a privately held company and therefore does not have a public stock price. However, you may access Generation Bio’s private market stock price with Forge Data.
plusminus
What is Generation Bio’s stock ticker symbol?
Generation Bio does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Other companies like Generation Bio in the BioTech & Pharma sector

Egenesis

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$387.57MM

Colossal Biosciences

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$1.01B

Prime Medicine

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$1.23B

ADARx Pharmaceuticals

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$827.77MM

Altos Labs

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$6.33B

Tempus

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$8.7B

Cytonics

Sector
Healthcare / BioTech & Pharma
 
 

Pendulum Therapeutics

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$308.05MM

AI Therapeutics

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$110MM

News Highlights

Xconomy 01/13/2020
Xconomy: Generation Bio Pockets $110M for Next Wave of Gene Therapy, IPO Plans
JP Morgan’s annual healthcare conference convenes in San Francisco this week and Generation Bio CEO Geoff McDonough is betting gene therapy will be among
FINSMES 01/10/2020
Generation Bio Raises $110M in Series C Financing | FinSMEs
Generation Bio, a Cambridge, MA-based gene therapy company, closed a $110m Series C financing. round led by T. Rowe Price funds and accounts
Business Wire 10/29/2019
Generation Bio Welcomes Steven Dowdy, Ph.D., to its Scientific Advisory Board
Generation Bio announced that Steven Dowdy, Ph.D., has joined its Scientific Advisory Board.

Trending Companies

Frequently Asked Questions

Updated on: Apr 23, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.